Mar 23, 2018 8:00am EDT OPKO Health Enrolls First Patient in Phase 2b Study of OPK88003 to Treat Type 2 Diabetes
Mar 16, 2018 8:00am EDT OPKO Health Announces Landmark Study Showing 4Kscore® Test is Strong Predictor of Prostate Cancer Mortality Published in European Urology
Mar 01, 2018 4:05pm EST OPKO Health Reports 2017 Fourth Quarter Business Highlights and Financial Results
Feb 26, 2018 4:05pm EST OPKO Health to Announce Fourth Quarter and Year End 2017 Financial Results on March 1, 2018
Jan 12, 2018 8:00am EST OPKO’S GeneDx Announces Research Collaboration with Radboud University Medical Center
Nov 27, 2017 11:02am EST OPKO Health Enrolls First Patient in Phase 2B Study of OPK88004 to Treat Benign Prostatic Hypertrophy